Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells

39Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

In this study, the gene copy number, mRNA and protein expression levels and nuclear DNA-binding activity of nuclear factor kappa B (NF-κB) were compared in a panel of five pairs of thymidylate synthase (TS) inhibitor-resistant and wild-type parent cancer cell lines. High constitutive NF-κB DNA-binding activity was detected in all chemoresistant cell lines. The upregulated NF-κB activity was composed of NF-κB subunits p50 and p65. Four out of five resistant cell lines constitutively overexpressed NF-κB p50 and p65 mRNA and protein. One resistant cell line with the highest NF-κB DNA-binding activity showed normal p50 and p65 protein expression. No NF-κB gene amplification was detected in resistant cell lines. Transient exposure of wild-type RKOWT and H630WT cells to 5-FU induced NF-κB DNA-binding activity but had no effect on NF-κB protein expression in these cells. Our results indicate that high constitutive NF-κB activity caused by its gene overexpression is an intrinsic character of TS inhibitor-resistant cells. NF-κB can antagonise anticancer drug-induced apoptosis. High NF-κB expression and nuclear activity in TS inhibitor-resistant cancer cells may play an important role in the chemoresistance. © 2003 Cancer Research UK.

Cite

CITATION STYLE

APA

Wang, W., & Cassidy, J. (2003). Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells. British Journal of Cancer, 88(4), 624–629. https://doi.org/10.1038/sj.bjc.6600753

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free